Alnylam Pharmaceuticals: TD Cowen cuts target price to $354 from $482
ALNY•TD Cowen cut its target price for Alnylam Pharmaceuticals to $354 from $482.
Related News

Sanofi Q3 2026 non-IFRS business EPS rises 22% to €3.55
SNY•

First Solar: RBC cuts target price to $232 from $236
FSLR•

Macquarie cuts MGM Resorts International target price to $46 from $48
MGM•

O'Reilly Automotive: Jefferies cuts target price to $108 from $115
ORLY•

Enerflex Ltd.: TD Cowen cuts target price to C$44 from C$46
EFX•